New era in prostate-cancer care: what we know and what we don't

Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade.

Cancer medicine·2017

The Health Effects of Masculine Self-Esteem Following Treatment for Localized Prostate Cancer Among Gay Men.

LGBT health·2015

Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies.

BJU international·2014

Using patient-reported outcomes to assess and improve prostate cancer brachytherapy.

BJU international·2013

Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance.

Urologic oncology·2013

Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.

Cancer·2013

Long-term exposure to wildfire-related PM2·5 and overall survival of older patients with lung cancer: a retrospective, registry-based cohort study.

The Lancet. Oncology·2026

Burden of cancer in Africa, 1990-2023: a systematic analysis from the Global Burden of Disease Study 2023.

The Lancet. Oncology·2026

Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial.

The Lancet. Oncology·2026

Development and external validation of a new prognostic model for metastatic clear cell renal cell carcinoma: a preregistered analysis using data from randomised clinical trials in the checkpoint inhibitor era.

The Lancet. Oncology·2026

Induction and extended consolidation with daratumumab, cyclophosphamide, bortezomib, lenalidomide, and dexamethasone in patients with high-risk multiple myeloma (OPTIMUM/MUKnine): 5-year follow-up of a multicentre, externally controlled, phase 2 trial.

The Lancet. Oncology·2026

Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial.

The Lancet. Oncology·2026

Toward Standardized Reporting in Non-Traumatic Osteonecrosis of the Femoral Head: Recommendations for Clinical Study Design and Reporting.

The Journal of arthroplasty·2026

Erratum.

Cells, tissues, organs·2026

Prognostic Role of Pretreatment Nutritional and Inflammatory Status in Unresectable Metastatic Colorectal Cancer: Supplementary Analysis of JCOG1007.

Annals of surgical oncology·2026

What happens next: unexpected malignancies after extracapsular dissection of parotid tumors.

Acta oto-laryngologica·2026

Renal Oncocytoma: A Case Report and Review of the Literature.

Cureus·2026

Nodal dissection in thymic surgery: a narrative review of the evolution of practice and evidence in the era of the 9th edition TNM classification (2000-2025).

Mediastinum (Hong Kong, China)·2026

Related Experiment Videos

New era in prostate-cancer care: what we know and what we don't

Related Concept Videos

Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade.

The Health Effects of Masculine Self-Esteem Following Treatment for Localized Prostate Cancer Among Gay Men.

Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies.

Using patient-reported outcomes to assess and improve prostate cancer brachytherapy.

Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance.

Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.

Long-term exposure to wildfire-related PM2·5 and overall survival of older patients with lung cancer: a retrospective, registry-based cohort study.

Burden of cancer in Africa, 1990-2023: a systematic analysis from the Global Burden of Disease Study 2023.

Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial.

Development and external validation of a new prognostic model for metastatic clear cell renal cell carcinoma: a preregistered analysis using data from randomised clinical trials in the checkpoint inhibitor era.

Induction and extended consolidation with daratumumab, cyclophosphamide, bortezomib, lenalidomide, and dexamethasone in patients with high-risk multiple myeloma (OPTIMUM/MUKnine): 5-year follow-up of a multicentre, externally controlled, phase 2 trial.

Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial.

Toward Standardized Reporting in Non-Traumatic Osteonecrosis of the Femoral Head: Recommendations for Clinical Study Design and Reporting.

Erratum.

Prognostic Role of Pretreatment Nutritional and Inflammatory Status in Unresectable Metastatic Colorectal Cancer: Supplementary Analysis of JCOG1007.

What happens next: unexpected malignancies after extracapsular dissection of parotid tumors.

Renal Oncocytoma: A Case Report and Review of the Literature.

Nodal dissection in thymic surgery: a narrative review of the evolution of practice and evidence in the era of the 9th edition TNM classification (2000-2025).

Related Experiment Videos

New era in prostate-cancer care: what we know and what we don't

Related Concept Videos

Related Articles